Skip to search formSkip to main contentSkip to account menu

tallysomycin A

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
SummaryTallysomycin S10b (TLM S10b), a structural analog of bleomycin (BLM), was evaluated and compared with BLM for antitumor… 
1990
1990
SummaryTwenty patients with advanced head and neck tumors were entered in a phase II trial of tallysomycin S10b given… 
1990
1990
SummaryA total of 16 patients with histologically confirmed colorectal cancer were entered into this phase II trial, designed to… 
1989
1989
The objective of this study was to compare the relative in vitro cytotoxicity of bleomycin to that of two newer-generation… 
1984
1984
Tallysomycin S10b, a biosynthetic derivative of tallysomycin B, was subjected to intravenous toxicologic studies in mice and dogs… 
1981
1981
Tallysomycin S10b is a biosynthetic derivative of tallysomycin B obtained by precursor amine-feeding fermentation. Tallysomycin… 
1981
1981
A series of new biosynthetic derivatives of tallysomycins A and B were obtained by precursor amine-feeding fermentation. Certain… 
1980
1980
The relative therapeutic and toxic effects of two new analogs were compared with bleomycin over a range of doses. Therapeutic…